Socioeconomic Disparities in Cancer Survival: Relation to Stage at Diagnosis, Treatment, and Centralization of Patients to Accredited Hospitals, 2005-2014, Japan
Overview
Authors
Affiliations
Background: Cancer survival varies by socioeconomic status in Japan. We examined the extent to which survival disparities are explained by factors relevant to cancer control measures (promoting early-stage detection, standardizing treatment, and centralizing patients to government-accredited cancer hospitals [ACHs]).
Methods: From the Osaka Cancer Registry, patients diagnosed with solid malignant tumors during 2005-2014 and aged 15-84 years (N = 376,077) were classified into quartiles using the Area Deprivation Index (ADI). Trends in inequalities were assessed for potentially associated factors: early-stage detection, treatment modality, and utilization of ACH (for first contact/diagnosis/treatment). 3-year all-cause survival was computed by the ADI quartile. Multivariable Cox regression models were used to assess survival disparities and their trends through a series of adjustment for the potentially associated factors.
Results: During 2005-2014, the most deprived ADI quartile had lower rates than the least deprived quartile for early-stage detection (42.6% vs. 48.7%); receipt of surgery (58.1% vs. 64.1%); and utilization of ACH (83.5% vs. 88.4%). While rate differences decreased for receipt of surgery and utilization of ACH (Annual Percent Change = -3.2 and - 11.9, respectively) over time, it remained unchanged for early-stage detection. During 2012-2014, the most deprived ADI quartile had lower 3-year survival than the least deprived (59.0% vs. 69.4%) and higher mortality (Hazard Ratio [HR] = 1.32, adjusted for case-mix): this attenuated with additional adjustment for stage at diagnosis (HR = 1.23); treatment modality (HR = 1.20); and utilization of ACH (HR = 1.19) CONCLUSIONS: Despite improvements in equalizing access to quality cancer care during 2005-2014, survival disparities remained. Interventions to reduce inequalities in early-stage detection could ameliorate such gaps.
Temporal changes in regional variations in cancer survival rates in Osaka, Japan (1997-2015).
Kato M, Morishima T, Sakaniwa R, Nakata K, Kuwabara Y, Ikawa T Sci Rep. 2025; 15(1):3854.
PMID: 39890938 PMC: 11785978. DOI: 10.1038/s41598-025-88052-x.
Nishioka D, Kanzaki I, Kihara A Palliat Med Rep. 2024; 5(1):187-193.
PMID: 39050774 PMC: 11265612. DOI: 10.1089/pmr.2023.0077.
Lee J, Park J, Kim N, Nari F, Bae S, Lee H JMIR Public Health Surveill. 2024; 10:e55011.
PMID: 39041282 PMC: 11284611. DOI: 10.2196/55011.
Tanaka H, Katanoda K, Togawa K, Kobayashi Y Int J Epidemiol. 2024; 53(2).
PMID: 38537248 PMC: 10972615. DOI: 10.1093/ije/dyae031.
Odani S, Tabuchi T, Nakaya T, Morishima T, Nakata K, Kuwabara Y Cancer Med. 2022; 12(5):6077-6091.
PMID: 36229942 PMC: 10028172. DOI: 10.1002/cam4.5332.